Dabrafenib and trametinib in the treatment of BRAF-mutated anaplastic thyroid cancers (ATC).

Authors: Irini Yacoub, Nancy Y. Lee, Nadeem Riaz, Sean Matthew McBride, Loren Scott Michel, Anuja Kriplani, Ian Ganly, Jennifer R. Cracchiolo, Richard J. Wong, Alan Loh Ho, Eric Jeffrey Sherman

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.6093

Source: Full article

---

Abstract

6093